Skip to main content
. 2022 Aug 2;18(3):492–496. doi: 10.4103/1673-5374.350190

Table 2.

Noggin treatment in animal models of spinal cord injury

Animal model Mode of spinal cord injury Noggin treatment Dose and route of administration Duration References
Sprague-Dawley rats (female) Contusion injury at T7 Recombinant human Noggin protein 1.2–2.4 μg/d intrathecal injections 3 d to 10 wk Hart et al., 2020
Mice (female) Contusion injury at T8 and T9 Recombinant mouse Noggin protein 15 ng/kg/d intrathecal injection with osmotic minipump 1 wk Xiao et al., 2010
Sprague-Dawley rats Transection injury at T10 Recombinant Noggin protein 1 µg/kg noggin injection 1 to 7 d Cui et al., 2015
Sprague-Dawley rats (female) Contusion injury at T9–T10 Recombinant mouse Noggin protein 17.8 μg/kg/d intrathecal injection with osmotic minipump 2 wk Matsuura et al., 2008
Adult Sprague-Dawley rats (male) Ligation of spinal nerve ligation at L5 (an animal model of neuropathic pain) Recombinant Noggin protein 5 µg/mL intrathecal injection 1 to 7 d Yang et al., 2019